November 15, 2001National Pharmpak Services Recalls
Zanesville, OH (SafetyAlerts)
- The Food and Drug Administration (FDA) said that National Pharmpak
Services, Inc is recalling Premarin Tablets (conjugated estrogen tablets USP),
1.25 mg,100 tablets per bottle.
This is the first public notice of
recall issued by the FDA.
Premarin Tablets (conjugated estrogen tablets USP), 1.25 mg,100 tablets per
bottle, Repackaged by National PharmPak Services, Inc., Zanesville, OH, Rx
only, NDC #0046-0866-81 (Wyeth-Ayerst),
Lot No. 9010249B, Exp. Date 09/03.
National Pharmpak Services, Inc., Zanesville, OH, by letter on 8/14/2001.
Ayerst Laboratories, Rouses Point, NY. Firm initiated recall is ongoing.
Dissolution failure (by manufacturer).
VOLUME OF PRODUCT IN COMMERCE
9851 bottles of 100 count.